Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, September 20 '25)

 


    J Infect

  1. GRANVIK C, Persson IL, Barros GWF, Ahlm C, et al
    Long-term Physical Capacity Following COVID-19: A Prospective, Three-Year Study.
    J Infect. 2025 Sep 12:106614. doi: 10.1016/j.jinf.2025.106614.
    PubMed         Abstract available


    J Med Virol

  2. BADAR N, Salman M, Ahad A, Mirza HA, et al
    Tracking SARS-CoV-2 Lineages in Pakistan's 2025 COVID-19 Resurgence: Insights From Genomic Surveillance.
    J Med Virol. 2025;97:e70607.
    PubMed        

  3. LIU S, Shao C, Ding Y, Wang Y, et al
    Ubiquitination: A Double-Edged Mechanism in Coronavirus Infections.
    J Med Virol. 2025;97:e70589.
    PubMed         Abstract available


    J Virol

  4. CHIOK KL, Jenik K, Fenton M, Falzarano D, et al
    MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures.
    J Virol. 2025 Sep 18:e0109825. doi: 10.1128/jvi.01098.
    PubMed         Abstract available

  5. JIAN X, Hu T, Xu H, Wen Y, et al
    An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.
    J Virol. 2025 Sep 16:e0117225. doi: 10.1128/jvi.01172.
    PubMed         Abstract available

  6. FARRUKEE R, Mordant F, Mackenzie-Kludas C, Mesner D, et al
    Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.
    J Virol. 2025 Sep 15:e0082325. doi: 10.1128/jvi.00823.
    PubMed         Abstract available

  7. WANG J, Sang X, Zheng W, Chan JF-W, et al
    Discovery of a potent covalent inhibitor that unusually distorts the catalytic dyad of SARS-CoV-2 main protease.
    J Virol. 2025 Sep 15:e0065825. doi: 10.1128/jvi.00658.
    PubMed         Abstract available

  8. YANG L, Qian Q, Sun Y-g, Chen X-x, et al
    PEDV Nsp14 induces mitophagy-mediated degradation of MAVS to antagonize host innate immunity and facilitate viral proliferation.
    J Virol. 2025;99:e0049825.
    PubMed         Abstract available


    Science

  9. COHEN J
    Florida plan to nix vaccine mandates raises alarm.
    Science. 2025;389:1075-1076.
    PubMed         Abstract available

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...